Upcoming Studies

The following studies are currently upcoming and looking for new patients.

1) Allergan Phase 3 Abicipar Pegol 150998-005 (Cedar Study): Safety and Efficacy in patients with Neovascular Age-Related Macular Degeneration

2) OHR Phase 3 Efficacy and Safety of Squalamine Lactate Opthalmic Solution(MAKO Study) 0.2% twice daily in subjects with Neovascular Age-Related Macular Degeneration

3) DRCR Protocol AB- Regeneron

Interested in this study and ready to enroll?

Click Here

Our Research Team

DRCR Protocol W

Dianelis: VA, assist Dr. in procedures

Lora, Francisco, Melvin, Cristal: OCT

Chanell: FA/FP

Ramona: Blood draw, back-up coordinator

Sasha: Dr.’s scribe

Elaine: Entering live data, HbA1C, urine lab, sending labs, regulatory paper work and keeping binder up to date, completing queries, assisting in site evaluations, making appointments for patients

Cedar/Allergan

Dianelis & Alma: VA

Lora, Francisco, Melvin, Cristal, Chanell: OCT

Chanell, Francisco: FA/FP

Ramona: Blood draw, calling day after procedures of the patient, back-up coordinator

Sasha: Dr.’s scribe-assistant in procedures

Elaine: Entering live data, HbA1C, urine lab, sending labs, regulatory paper work and keeping binder up to date, completing queries, assisting in site evaluations, questionnaires given to patient, making appointments for patients

Protocol GO29665

Elaine: Sending info and keeping regulatory documents and making appointments for patients

Techs & Scribe: can be any

OHR/Mako

Dianelis & Alma: VA

Lora, Francisco, Melvin, Cristal: OCT

Chanell & Francisco: FA/FP

Ramona: Blood draw, calling day after procedures of the patient, back-up coordinator

Sasha: Dr.’s scribe-assistant in procedures

Elaine: Entering live data, HbA1C, urine lab, sending labs, regulatory paper work and keeping binder up to date, completing queries, assisting in site evaluations, questionnaires given to patient, making appointments for patients